ABVX
ABVX
Positions held
Your positionsABVX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · Abivax (ABVX): Cleared Safety Overhang and Phase 3 Data De-Risk Path to Commercialization
2026-09-30 · Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
2026-09-27 · ABIVAX Société Anonyme (ENXTPA:ABVX) Just Gave Investors Something To Think About
2026-09-26 · ABIVAX Société Anonyme (ENXTPA:ABVX) Appoints New Chief Medical And Technical Officers
2026-09-26 · ABIVAX (ABVX) Uses More Cash. Can its Funding Cover a Potential Launch?
2026-09-22 · Wedbush Cuts Price Target on Abivax to $118 From $160, Keeps Neutral Rating
2026-09-21 · Abivax Says Chris Rabbat to Succeed Fabio Cataldi as Chief Medical Officer
2026-09-21 · Abivax Presents Business Updates and First Half 2026 Financial Results
2026-09-18 · 4 Biotech Stocks to Watch as Potential Takeover Targets
2026-09-11 · Earnings To Watch: Abivax SA (XPAR:ABVX) Reports Q2 2026 Result
2026-09-10 · Goldman Sachs Initiates Coverage on Abivax With Buy Rating, $155 Price Target
2026-09-08 · Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why
Price (daily)
Full chart · RSI · MACD · patterns